Fasikl-X™ Nerve-Computer Interface

About Fasikl

Fasikl is a private, clinical-stage biotech company developing AI-driven neuromodulation therapies. The company has achieved a significant milestone with the FDA clearance of its first product, Felix, for essential tremor, validating its core neuro-AI platform. Built on over two decades of foundational R&D, Fasikl's technology includes advanced neural interfaces and AI models capable of single-fiber resolution recording and stimulation. The company is positioned to expand its platform into a broad pipeline of neurological indications and next-generation nerve-computer interfaces.

Therapeutic Areas